Nancy R. Gough
Abstract
A screen of irreversible inhibitors targeting the drug-resistant mutant form of the EGFR yields new candidates for treatment of non–small-cell lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A screen of irreversible inhibitors targeting the drug-resistant mutant form of the EGFR yields new candidates for treatment of non–small-cell lung cancer.
Key concepts: Biology, Medicine, Computational biology